Indication
Non-Invasive Bladder Urothelial Carcinoma
2 clinical trials
2 products
Product
Bacillus Calmette-GuerinClinical trial
A Multicenter, Randomized, Double-blind, Controlled Phase III Non-inferiority Study Assessing Efficacy and Safety of VERITY-BCG in Management of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC) in BCG-naïve Patients.Status: Not yet recruiting, Estimated PCD: 2025-12-30
Clinical trial
Phase 1 Clinical Trial of Intravesical Adoptive Cell Therapy {ACT) With Tumor Infiltrating Lymphocytes (TIL) for Patients With BCG Exposed High Grade Non-Muscle Invasive Bladder Cancer (NMIBC)Status: Recruiting, Estimated PCD: 2024-11-01